SCHEMBL731350

SCHEMBL731350

O[C@@H]1CC2CCN1CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72375 1.00
SCHEMBL728782 1.00
Hydrochloric Acid SCHEMBL4090424 0.97 GAA (0.32)
Hydrochloric Acid SCHEMBL27676966 0.97 GAA (0.32)
SCHEMBL2336833 0.82
SCHEMBL10401754 0.80 POLB (0.32)
SCHEMBL11350359 0.71
SCHEMBL6152816 0.69
SCHEMBL5180410 0.69
SCHEMBL4279010 0.67 SLC18A3 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104830814-A Carbonyl reductase and application thereof in preparation of (R)-quinuclidinol NANJING ABIOCHEM BIOMEDICAL TECHNOLOGY CO LTD 2015-08-12 CN claimed
US-9018379-B1 Process of preparing solifenacin or salt thereof, and novel intermediate used in the process KYUNG DONG PHARM. CO., LTD. (KR) 2015-04-28 US claimed
US-20150112072-A1 PROCESS OF PREPARING SOLIFENACIN OR SALT THEREOF, AND NOVEL INTERMEDIATE USED IN THE PROCESS KYUNG DONG PHARM. CO., LTD. (KR) 2015-04-23 US claimed
EP-2831070-A1 PROCESS OF PREPARING SOLIFENACIN OR SALT THEREOF, AND NOVEL INTERMEDIATE USED IN THE PROCESS Kyung Dong Pharm. Co., Ltd. (KR) 2015-02-04 EP claimed
CN-103702997-A Process for the preparation of solifenacin and salts thereof ISOCHEM SA 2014-04-02 CN claimed
WO-2013147458-A1 PROCESS OF PREPARING SOLIFENACIN OR SALT THEREOF, AND NOVEL INTERMEDIATE USED IN THE PROCESS KYUNG DONG PHARM. CO., LTD. (KR) 2013-10-03 WO claimed
CN-113387829-B Preparation method of shakubiqu 凯特立斯(深圳)科技有限公司 2023-04-07 CN disclosed
EP-3256464-B1 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2022-05-11 EP disclosed
CN-113387829-A Preparation method of shakubiqu 凯特立斯(深圳)科技有限公司 2021-09-14 CN disclosed
CN-107207473-B Compounds having muscarinic receptor antagonist and β 2 adrenergic receptor agonist activity 奇斯药制品公司 2020-07-07 CN disclosed
CN-107384885-B Application of imine reductase and mutant thereof in synthesis of (S) -1-aryl-1, 2, 3, 4-tetrahydroisoquinoline 武汉大学 2019-12-24 CN disclosed
CN-106282135-B It the preparation method of quinine ketoreductase RrQR a kind of and its is applied in preparation (R) -3- quinuclidinol 河北省科学院生物研究所 2019-09-27 CN disclosed
WO-2018150437-A1 A PROCESS FOR PREPARING ACLIDINIUM BROMIDE AND INTERMEDIATES THEREOF GBR LABORATORIES PVT. LTD (IN) 2018-08-23 WO disclosed
US-5888804-A SIMPLE AND EFFICIENT BIOSYNTHESIS BY INCUBATING MICROORGANISM WITB QUINUCLIDINONE, RECOVERING OR HARVESTING PRODUCT DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-30 US disclosed
EP-0863212-A2 Processes for production of optical active quinuclidinol Daicel Chemical Industries, Ltd. (JP) 1998-09-09 EP disclosed
US-5569447-A TOMOGRAPHIC IMAGING AGENTS THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-10-29 US disclosed
US-5387409-A Diagnostic imaging agents, e.g. hypoxic tissue; radiotherapy; kits BRACCO INTERNATIONAL B.V. (NL) 1995-02-07 US disclosed
EP-0577253-A2 Enantiomeric enrichment of (R,S)-3-quinuclidinol BEND RESEARCH, INC. (US) 1994-01-05 EP disclosed
US-5215918-A Acid anhydride esterification; preferential enzymatic hydrolysis with a subtilisin protease BEND RESEARCH, INC. (US) 1993-06-01 US disclosed
EP-0441491-A1 Boronic acid adducts of rhenium dioxime and technetium-99M dioxime complexes containing a biochemically active group BRACCO INTERNATIONAL B.V. (NL) 1991-08-14 EP disclosed